TWD 102.0
(-0.49%)
Year | Net Income | Net Income Growth |
---|---|---|
2023 | 158.75 Million TWD | 42.69% |
2022 | 111.26 Million TWD | 20.77% |
2021 | 92.13 Million TWD | -7.58% |
2020 | 99.68 Million TWD | 1165.24% |
2019 | -9.35 Million TWD | 0.0% |
Year | Net Income | Net Income Growth |
---|---|---|
2024 Q2 | 31.92 Million TWD | 0.0% |
2024 Q1 | 31.92 Million TWD | -25.73% |
2023 Q2 | 36.39 Million TWD | 0.0% |
2023 Q4 | 42.98 Million TWD | 0.0% |
2023 FY | 158.75 Million TWD | 42.69% |
2023 Q1 | 36.39 Million TWD | 5.25% |
2023 Q3 | 42.98 Million TWD | 18.12% |
2022 Q3 | 34.57 Million TWD | 0.0% |
2022 FY | 111.26 Million TWD | 20.77% |
2022 Q4 | 34.57 Million TWD | 0.0% |
2021 FY | 92.13 Million TWD | -7.58% |
2020 FY | 99.68 Million TWD | 1165.24% |
2019 FY | -9.35 Million TWD | 0.0% |
Name | Net Income | Net Income Difference |
---|---|---|
Allied Biotech Corporation | 97.41 Million TWD | -62.973% |
GeneFerm Biotechnology Co., Ltd. | 124.62 Million TWD | -27.39% |
Easywell Biomedicals, Inc. | -144.81 Million TWD | 209.624% |
TTY Biopharm Company Limited | 1.12 Billion TWD | 85.932% |
Synmosa Biopharma Corporation | 594.83 Million TWD | 73.311% |
Orient EuroPharma Co., Ltd. | 143.94 Million TWD | -10.29% |
Center Laboratories, Inc. | -995.42 Million TWD | 115.949% |
Tien Liang BioTech Co., Ltd. | 17.73 Million TWD | -795.302% |
Orient Pharma Co., Ltd. | 22.28 Million TWD | -612.289% |
InnoPharmax Inc. | -70.83 Million TWD | 324.132% |
Johnson Chemical Pharmaceutical Works Co., Ltd. | 79.7 Million TWD | -99.191% |
Excelsior Biopharma Inc. | -91.01 Million TWD | 274.435% |
DV Biomed Co., Ltd. | 162.91 Million TWD | 2.55% |
Foresee Pharmaceuticals Co., Ltd. | -1.03 Billion TWD | 115.319% |
Handa Pharmaceuticals, Inc. | 726.88 Million TWD | 78.16% |
UniPharma Co., Ltd. | -21.81 Million TWD | 827.8% |
Anxo Pharmaceutical Co., Ltd. | 21.86 Million TWD | -626.202% |
Alar Pharmaceuticals Inc. | 382.61 Million TWD | 58.508% |
Mercury Biopharmaceutical Corporation | -43.81 Million TWD | 462.322% |
Bioray Biotech Co., Ltd | -11.55 Million TWD | 1473.432% |
TSH Biopharm Corporation Limited | 61.98 Million TWD | -156.102% |